Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (51-60 of 263) with videos related to

Pageof 27
Sort By:
Translational Cancer Research|July 28, 2015
Cancer biomarker discovery and validationNicolas Goossens, Shigeki Nakagawa, Xiaochen Sun, et al.
Current Cancer Drug Targets|August 10, 2012
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesYujin Hoshida, Bryan C Fuchs, Kenneth K Tanabe
Journal of Liver Cancer|December 5, 2024
Molecular and immune landscape of hepatocellular carcinoma for therapeutic developmentHiroyuki Suzuki, Sumit Mishra, Subhojit Paul, et al.
Journal of Hepatology|October 10, 2017
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicineNaoto Fujiwara, Scott L Friedman, Nicolas Goossens, et al.
BMC Medicine|March 15, 2017
Hepatitis C-related hepatocellular carcinoma in the era of new generation antiviralsThomas F Baumert, Frank Jühling, Atsushi Ono, et al.
Gastroenterology|October 25, 2016
Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver DiseasesBenjamin Wooden, Nicolas Goossens, Yujin Hoshida, et al.
Seminars in Liver Disease|September 14, 2022
Hepatocellular Carcinoma Chemoprevention with Generic AgentsFahmida Rasha, Subhojit Paul, Tracey G Simon, et al.
Hepatology (Baltimore, Md.)|September 9, 2022
Risk stratification and early detection biomarkers for precision HCC screeningYi-Te Lee, Naoto Fujiwara, Ju Dong Yang, et al.
Hepatology (Baltimore, Md.)|June 10, 2023
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-makingRenumathy Dhanasekaran, Hiroyuki Suzuki, Lea Lemaitre, et al.
Seminars in Oncology|August 1, 2012
Gene signatures in the management of hepatocellular carcinomaYujin Hoshida, Agrin Moeini, Clara Alsinet, et al.
Pageof 27

Showing results (51-60 of 263) with videos related to

Sort By:
Pageof 27
Translational Cancer Research|July 28, 2015
Cancer biomarker discovery and validationNicolas Goossens, Shigeki Nakagawa, Xiaochen Sun, et al.
Current Cancer Drug Targets|August 10, 2012
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesYujin Hoshida, Bryan C Fuchs, Kenneth K Tanabe
Journal of Liver Cancer|December 5, 2024
Molecular and immune landscape of hepatocellular carcinoma for therapeutic developmentHiroyuki Suzuki, Sumit Mishra, Subhojit Paul, et al.
Journal of Hepatology|October 10, 2017
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicineNaoto Fujiwara, Scott L Friedman, Nicolas Goossens, et al.
BMC Medicine|March 15, 2017
Hepatitis C-related hepatocellular carcinoma in the era of new generation antiviralsThomas F Baumert, Frank Jühling, Atsushi Ono, et al.
Gastroenterology|October 25, 2016
Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver DiseasesBenjamin Wooden, Nicolas Goossens, Yujin Hoshida, et al.
Seminars in Liver Disease|September 14, 2022
Hepatocellular Carcinoma Chemoprevention with Generic AgentsFahmida Rasha, Subhojit Paul, Tracey G Simon, et al.
Hepatology (Baltimore, Md.)|September 9, 2022
Risk stratification and early detection biomarkers for precision HCC screeningYi-Te Lee, Naoto Fujiwara, Ju Dong Yang, et al.
Hepatology (Baltimore, Md.)|June 10, 2023
Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-makingRenumathy Dhanasekaran, Hiroyuki Suzuki, Lea Lemaitre, et al.
Seminars in Oncology|August 1, 2012
Gene signatures in the management of hepatocellular carcinomaYujin Hoshida, Agrin Moeini, Clara Alsinet, et al.
Pageof 27